1. The sertraline prescriptions were calculated as a total of prescriptions for Zoloft and generic Sertraline using data from the charts for generic and brand name drugs.Top 200 generic drugs by units in 2006. Top 200 brand-name drugs by units.. Drug Topics, Mar 5, 2007. Retrieved on 2007-07-03.
2. The most complete account has been presented in: Mullin R (2006). "ACS Award for Team Innovation". Chemical & Engineering News 84 (5): 45-52.
3. A short blurb on the history of sertraline, see: Couzin J (2005). "The brains behind blockbusters". Science 309 (5735): 728. doi:10.1126/science.309.5735.728. PMID 16051786.
4. For the structure of tametraline, see: tametraline HCl CP 24441-1 (Pfizer). Retrieved on 2007-07-03.
5. FDA (1990). Minutes of the 33rd Meeting of Psychopharmacological Drugs Advisory Committee on November 19, 1990 (PDF). Retrieved on 2007-07-20.
6. See also:Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dubé S, Small JG (1995). "Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo". Biol. Psychiatry 38 (9): 592-602. doi:10.1016/0006-3223(95)00178-8. PMID 8573661.
7. MHRA (2003-12-10). Safety review of antidepressants used by children completed. Retrieved on 2007-07-05.
8. Boseley, Sarah. "Drugs for depressed children banned", The Guardian, December 10, 2003. Retrieved on 2007-04-19.
9. MHRA. Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents. Retrieved on 2007-07-05.
10. Smith, Aaron (July 17, 2006). Pfizer needs more drugs. CNNMoney.com. Retrieved on 2007-01-27.
11. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W. (1997). "Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.". The Journal of the American Medical Association 278 (12): 983-988. PMID 9307345.
12. Londborg PD, Wolkow R, Smith WT, DuBoff E, England D, Ferguson J, Rosenthal M, Weise C. (1998). "Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation.". The British Journal of Psychiatry 173: 54-60. PMID 9850204.
13. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC. (1995). "Sertraline for social phobia: a double-blind, placebo-controlled crossover study.". The American Journal of Psychiatry 152 (9): 1368-1371. PMID 7653696.
14. Ravindran AV, Guelfi JD, Lane RM, Cassano GB (2000). "Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression". The Journal of clinical psychiatry 61 (11): 821–7. PMID 11105734.
15. a b Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1996). "A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia". Arch. Gen. Psychiatry 53 (9): 777–84. PMID 8792754.
16. Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W (2000). "Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders". Arch. Gen. Psychiatry 57 (1): 76–82. PMID 10632236.
17. Lépine JP, Goger J, Blashko C, Probst C, Moles MF, Kosolowski J, Scharfetter B, Lane RM (2000). "A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression". International clinical psychopharmacology 15 (5): 263—71. PMID 10993128.
18. a b Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J (1990). "Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression". The Journal of clinical psychiatry 51 Suppl B: 18-27. PMID 2258378.
19. a b c d Lydiard RB, Stahl SM, Hertzman M, Harrison WM (1997). "A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression". The Journal of clinical psychiatry 58 (11): 484-91. PMID 9413414.
20. Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME (1998). "The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies". The Journal of clinical psychiatry 59 (11): 589-97. PMID 9862605.
21. a b Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM (1998). "The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine". The Journal of clinical psychiatry 59 (11): 598-607. PMID 9862606.
22. a b Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB (1998). "The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine". The Journal of clinical psychiatry 59 (11): 608-19. PMID 9862607.
23. Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB (2001). "Sertraline versus imipramine to prevent relapse in chronic depression". Journal of affective disorders 65 (1): 27-36. PMID 11426506.
24. Papakostas GI, Fava M (2006). "A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder". Canadian journal of psychiatry. Revue canadienne de psychiatrie 51 (12): 783-90. PMID 17168253.
25. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS (1996). "Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction". The Journal of clinical psychiatry 57 Suppl 2: 53-62. PMID 8626364.
26. Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M (2007). "Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial". Current medical research and opinion 23 (2): 245-50. doi:10.1185/030079906X167273. PMID 17288677.
27. a b c d Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA (1997). "Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients". The Journal of clinical psychiatry 58 (12): 532-7. PMID 9448656.
28. For the review, see:Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS (2005). "Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder". Ann. Intern. Med. 143 (6): 415-26. PMID 16172440.
29. Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C (2005). "Fluoxetine versus other types of pharmacotherapy for depression". Cochrane database of systematic reviews (Online) (4): CD004185. doi:10.1002/14651858.CD004185.pub2. PMID 16235353.
30. Mehtonen OP, Søgaard J, Roponen P, Behnke K (2000). "Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group". The Journal of clinical psychiatry 61 (2): 95-100. PMID 10732656.
31. Shelton RC, Haman KL, Rapaport MH, Kiev A, Smith WT, Hirschfeld RM, Lydiard RB, Zajecka JM, Dunner DL (2006). "A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder". The Journal of clinical psychiatry 67 (11): 1674-81. PMID 17196045.
32. Wise TN, Sheridan MJ (2000). "Venlafaxine versus sertraline for major depressive disorder". The Journal of clinical psychiatry 61 (11): 873-4. PMID 11105744.
33. Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T (2005). "Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms". The Journal of clinical psychiatry 66 (10): 1312-20. PMID 16259546.
34. Muijsers RB, Plosker GL, Noble S (2002). "Sertraline: a review of its use in the management of major depressive disorder in elderly patients". Drugs & aging 19 (5): 377-92. PMID 12093324.
35. Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K (2003). "An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression". The American journal of psychiatry 160 (7): 1277-85. PMID 12832242.
36. BERNARD J. CARROLL (html). Retrieved on 2007-08-08.
37. Carroll BJ (2004). "Sertraline and the Cheshire cat in geriatric depression". The American journal of psychiatry 161 (4): 759; author reply 759-61. PMID 15056533.
38. Kronig MH, Apter J, Asnis G, Bystritsky A, Curtis G, Ferguson J, Landbloom R, Munjack D, Riesenberg R, Robinson D, Roy-Byrne P, Phillips K, Du Pont IJ. (1999). "Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.". Journal of Clinical Psychopharmacology 19 (2): 172-176. PMID 10211919.
39. Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA (1990). "Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder". Psychopharmacology bulletin 26 (3): 279–84. PMID 2274626.
40. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K (1995). "Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder". Arch. Gen. Psychiatry 52 (4): 289–95. PMID 7702445.
41. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV (2003). "Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder". The American journal of psychiatry 160 (11): 1919–28. PMID 14594734.
42. Flament MF, Bisserbe JC (1997). "Pharmacologic treatment of obsessive-compulsive disorder: comparative studies". The Journal of clinical psychiatry 58 Suppl 12: 18–22. PMID 9393392.
43. Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V (2002). "Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study". Journal of clinical psychopharmacology 22 (2): 148–54. PMID 11910259.
44. Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C (2006). "High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial". The Journal of clinical psychiatry 67 (1): 15–22. PMID 16426083.
45. Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B (1995). "A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder". International clinical psychopharmacology 10 (2): 57–65. PMID 7673657.
46. Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K (1997). "A 2-year study of sertraline in the treatment of obsessive-compulsive disorder". International clinical psychopharmacology 12 (6): 309–16. PMID 9547132.
47. Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D (2002). "Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder". The American journal of psychiatry 159 (1): 88–95. PMID 11772695.
48. (2004) "Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial". JAMA 292 (16): 1969–76. doi:10.1001/jama.292.16.1969. PMID 15507582.
49. Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV (2006). "A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder". The Journal of clinical psychiatry 67 (7): 1133–9. PMID 16889458.
50. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000). "Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial". JAMA 283 (14): 1837–44. PMID 10770145.
51. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001). "Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder". Arch. Gen. Psychiatry 58 (5): 485–92. PMID 11343529.
52. Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM (2001). "Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment". The Journal of clinical psychiatry 62 (5): 325–31. PMID 11411812.
53. a b Davis LL, Frazier EC, Williford RB, Newell JM (2006). "Long-term pharmacotherapy for post-traumatic stress disorder". CNS drugs 20 (6): 465–76. PMID 16734498.
54. Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G (2001). "Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study". The American journal of psychiatry 158 (12): 1974–81. PMID 11729012.
55. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ (2006). "Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study". Journal of clinical psychopharmacology 26 (3): 259–67. doi:10.1097/01.jcp.0000222514.71390.c1. PMID 16702890.
56. Tucker P, Potter-Kimball R, Wyatt DB, Parker DE, Burgin C, Jones DE, Masters BK (2003). "Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo". Psychopharmacology bulletin 37 (3): 135–49. PMID 14608246.
57. McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W (2004). "Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder". Depression and anxiety 19 (3): 190–6. doi:10.1002/da.20008. PMID 15129422.
58. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C (2002). "Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder". Journal of clinical psychopharmacology 22 (2): 190–5. PMID 11910265.
59. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM (2007). "Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting". The Journal of clinical psychiatry 68 (5): 711–20. PMID 17503980.
60. Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM. (2004). "Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.". The American Journal of Psychiatry 161: 1642-1649. PMID 15337655.
61. McElroy SL, Casuto LS, Nelson EB, Lake KA, Soutullo CA, Keck PE Jr, Hudson JI. (2000). "Placebo-controlled trial of sertraline in the treatment of binge eating disorder.". The American Journal of Psychiatry 157 (6): 1004-1006. PMID 10831483.
62. McMahon CG. (1998). "Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study.". The Journal of Urology 159 (6): 1935-1938. PMID 9598491.
63. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. (1994). "Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.". Journal of the American College of Cardiology 24 (2): 490-494. PMID 8034887.
64. Kavoussi RJ, Liu J, Coccaro EF. (1994). "An [[open trial (medical)|]] of sertraline in patients with personality disorder who also have impulsive aggression.". Journal of Clinical Psychiatry 55 (4): 137-141. PMID 8071257.
65. a b c d e [www.zoloft.com/ Zoloft Prescribing Information for the U.S.] (PDF). Pfizer. Retrieved on 2007-09-09.
66. Fernández-Bañares F, Esteve M, Espinós JC, Rosinach M, Forné M, Salas A, Viver JM (2007). "Drug consumption and the risk of microscopic colitis". Am. J. Gastroenterol. 102 (2): 324–30. doi:10.1111/j.1572-0241.2006.00902.x. PMID 17100977.
67. Olivera AO (1997). "Sertraline and akathisia: spontaneous resolution". Biol. Psychiatry 41 (2): 241–2. PMID 9018398.
68. Review:Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of clinical psychiatry 57 (10): 449–54. PMID 8909330.
69. Lauterbach EC, Meyer JM, Simpson GM (1997). "Clinical manifestations of dystonia and dyskinesia after SSRI administration". The Journal of clinical psychiatry 58 (9): 403–4. PMID 9378692.
70. Walker L (2002). "Sertraline-induced akathisia and dystonia misinterpreted as a panic attack". Psychiatric services (Washington, D.C.) 53 (11): 1477–8. PMID 12407283.
71. Hansen L (2001). "A critical review of akathisia, and its possible association with suicidal behaviour" 16 (7): 495–505. doi:10.1002/hup.325. PMID 12404546.
72. Hansen L, Kingdom D (2006). "Akathisia as a risk factor for suicide". The British journal of psychiatry : the journal of mental science 188: 192. doi:10.1192/bjp.188.2.192. PMID 16449715.
73. Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC (2000). "Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment". The Journal of clinical psychiatry 61 (11): 863—7. PMID 11105740.
74. a b Maina G, Albert U, Salvi V, Bogetto F (2004). "Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors". The Journal of clinical psychiatry 65 (10): 1365-71. PMID 15491240.
75. Schmitt JA, Kruizinga MJ, Riedel WJ (2001). "Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors". J. Psychopharmacol. (Oxford) 15 (3): 173–9. PMID 11565624.
76. Siepmann M, Grossmann J, Mück-Weymann M, Kirch W (2003). "Effects of sertraline on autonomic and cognitive functions in healthy volunteers". Psychopharmacology (Berl.) 168 (3): 293–8. doi:10.1007/s00213-003-1448-4. PMID 12692706.
77. Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (2006). "Cognitive performance in depressed patients after chronic use of antidepressants". Psychopharmacology (Berl.) 185 (1): 84–92. doi:10.1007/s00213-005-0274-2. PMID 16485140.
78. Hostetter A, Ritchie JC, Stowe ZN (2000). "Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women". Biol. Psychiatry 48 (10): 1032-4. PMID 11082480.
79. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D (2003). "Placental passage of antidepressant medications". The American journal of psychiatry 160 (5): 993-6. PMID 12727706.
80. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA (2007). "First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects". N. Engl. J. Med. 356 (26): 2675–83. doi:10.1056/NEJMoa067407. PMID 17596601.
81. Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, Nemeroff CB (2003). "The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations". The Journal of clinical psychiatry 64 (1): 73–80. PMID 12590627.
82. Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM (2001). "Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs". The American journal of psychiatry 158 (10): 1631-7. PMID 11578995.
83. a b Ferguson JM (2001). "The effects of antidepressants on sexual functioning in depressed patients: a review". The Journal of clinical psychiatry 62 Suppl 3: 22-34. PMID 11229450.
84. a b Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA (1999). "A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline". Clinical therapeutics 21 (4): 643-58. doi:10.1016/S0149-2918(00)88317-4. PMID 10363731.
85. Levenson M, Holland C. Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006). Retrieved on 2007-05-13.
86. a b c Stone MB, Jones ML (November 17, 2006). CLINICAL REVIEW: RELATIONSHIP BETWEEN ANTIDEPRESSANT DRUGS AND SUICIDALITY IN ADULTS (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC) 11-74. FDA. Retrieved on 2007-09-22.
87. a b Levenson M, Holland C (November 17, 2006). Statistical Evaluation of Suicidality in Adults Treated with Antidepressants (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC) 75-140. FDA. Retrieved on 2007-09-22.
88. Pfizer Inc. (November 30, 2006). Memorandum from Pfizer Global Pharmaceuticals Re: DOCKET: 2006N-0414 –“SUICIDALITY DATA FROM ADULT ANTIDIPRESSANT TRIALS” ZOLOFT SERTRALINE HYDROCHLORIDE) TABLETS & ORAL CONCENTRATE BACKGROUND PACKAGE FOR DECEMBER 13 ADVISORY COMMITTEE (PDF). FDA DOCKET 2006N-0414. FDA. Retrieved on 2007-09-25.
89. CSM EXPERT WORKING GROUP ON THE SAFETY OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS (Decemver 2004). [www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf REPORT OF THE CSM EXPERT WORKING GROUP ON THE SAFETY OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS] (PDF). MHRA. Retrieved on 2007-09-25.
90. Gunnell D, Saperia J, Ashby D (2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". BMJ 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMID 15718537. Retrieved on 2007-09-25.
91. a b Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB (1998). "Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial". Biol. Psychiatry 44 (2): 77—87. PMID 9646889.
92. Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004). "Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study". The American journal of psychiatry 161 (5): 826–35. PMID 15121647.
93. a b Owens MJ, Knight DL, Nemeroff CB (2001). "Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine". Biol. Psychiatry 50 (5): 345–50. PMID 11543737.
94. Narita N, Hashimoto K, Tomitaka S, Minabe Y (1996). "Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain". Eur. J. Pharmacol. 307 (1): 117–9. PMID 8831113.
95. a b Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites". J. Pharmacol. Exp. Ther. 283 (3): 1305–22. PMID 9400006.
96. a b c d e DeVane CL, Liston HL, Markowitz JS (2002). "Clinical pharmacokinetics of sertraline". Clinical pharmacokinetics 41 (15): 1247–66. PMID 12452737.
97. Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K (1999). "Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro". Drug Metab. Dispos. 27 (7): 763–6. PMID 10383917.
98. a b c Obach RS, Cox LM, Tremaine LM (2005). "Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study". Drug Metab. Dispos. 33 (2): 262–70. doi:10.1124/dmd.104.002428. PMID 15547048.
99. Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M (1996). "The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin". Clin. Pharmacol. Ther. 60 (5): 512–21. doi:10.1016/S0009-9236(96)90147-2. PMID 8941024.
100. Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH (2001). "Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19". Clin. Pharmacol. Ther. 70 (1): 42–7. doi:10.1067/mcp.2001.116513. PMID 11452243.
101. a b Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (2006). "The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions". J. Pharmacol. Exp. Ther. 316 (1): 336–48. doi:10.1124/jpet.105.093229. PMID 16192315.
102. Preskorn SH, Greenblatt DJ, Flockhart D, Luo Y, Perloff ES, Harmatz JS, Baker B, Klick-Davis A, Desta Z, Burt T (2007). "Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers". Journal of clinical psychopharmacology 27 (1): 28–34. PMID 17224709.
103. Hamilton SP, Nunes EV, Janal M, Weber L (2000). "The effect of sertraline on methadone plasma levels in methadone-maintenance patients". The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 9 (1): 63–9. PMID 10914294.
104. DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L (2004). "Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers". Journal of clinical psychopharmacology 24 (1): 4–10. doi:10.1097/01.jcp.0000104908.75206.26. PMID 14709940.
105. Lacasse J, Leo J (2005). "Serotonin and depression: a disconnect between the advertisements and the scientific literature". PLoS Med 2 (12): e392. doi:10.1371/journal.pmed.0020392.g001. PMID 16268734. Free full text, open-access source
106. Food and Drug Administration Division of Drug Marketing Advertising and Communications. (2005) Zoloft warning letter.. Retrieved on 2007-11-03.
107. Regina v Hawkins [2001 NSWSC 420]. New South Wales Supreme Court (May 24, 2001). Retrieved on 2007-11-03.
108. Business Wire (July 23, 2004). Suit Claims Pfizer Conceals Evidence and Misleads Doctors and Patients About Safety and Effectiveness of Zoloft. Press release. Retrieved on 2007-04-19.
109. Enter the case number "BC 318871" into the form to see the summary of the case stating that the suit was dismissed. The images of the case documents are available for a nominal price. Los Angeles Superior Court - Civil Case Summary (2005-05-31). Retrieved on 2007-11-04. “It is thereby ordered, adjudged and decreed that this action is dismissed and that Defendant Pfizer Inc is awarded its costs of suit incurred therein.”